AmCad BioMed Corporation (TPEX:4188)
Taiwan
· Delayed Price · Currency is TWD 13.00
+0.05 (0.39%)
Mar 10, 2026, 1:30 PM CST
AmCad BioMed Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 24.6 | 17.76 | 29.66 | 47.04 | 58.51 | Upgrade
|
| Short-Term Investments | 346.62 | 343.95 | 252.61 | 280.78 | 312.54 | Upgrade
|
| Trading Asset Securities | - | 4 | 5 | 3.02 | - | Upgrade
|
| Cash & Short-Term Investments | 371.22 | 365.71 | 287.27 | 330.84 | 371.05 | Upgrade
|
| Cash Growth | 1.51% | 27.30% | -13.17% | -10.84% | -6.09% | Upgrade
|
| Accounts Receivable | 9.34 | 20.66 | 11.35 | 4.51 | 5.78 | Upgrade
|
| Other Receivables | 0.02 | 0.01 | - | 0.06 | 0.13 | Upgrade
|
| Receivables | 9.37 | 20.66 | 11.35 | 4.57 | 5.91 | Upgrade
|
| Inventory | 27.34 | 30.09 | 25.02 | 23.33 | 21.24 | Upgrade
|
| Prepaid Expenses | 2.04 | 1.28 | 2.07 | 1.02 | 2.03 | Upgrade
|
| Other Current Assets | 0.03 | 0.34 | 0.18 | 0.12 | 0.31 | Upgrade
|
| Total Current Assets | 410 | 418.09 | 325.89 | 359.88 | 400.54 | Upgrade
|
| Property, Plant & Equipment | 75.21 | 82.92 | 82.71 | 79.81 | 88.23 | Upgrade
|
| Long-Term Investments | 75.8 | 125.68 | 28.06 | 28.74 | 34.47 | Upgrade
|
| Goodwill | - | 31.18 | 31.18 | 31.18 | 31.18 | Upgrade
|
| Other Intangible Assets | 59.94 | 35.15 | 42.5 | 50.54 | 58.62 | Upgrade
|
| Other Long-Term Assets | 1.75 | 1.87 | 2.3 | 3.72 | 2.72 | Upgrade
|
| Total Assets | 622.7 | 694.87 | 512.65 | 553.86 | 615.75 | Upgrade
|
| Accounts Payable | 1.32 | 2.74 | 1.95 | 1.06 | 1.15 | Upgrade
|
| Current Portion of Leases | 1.31 | 5.15 | 4.4 | 3.88 | 4.42 | Upgrade
|
| Current Unearned Revenue | 0.46 | 0.51 | 2.05 | 2.67 | 5.45 | Upgrade
|
| Other Current Liabilities | 15.04 | 16.75 | 16.02 | 19.75 | 15.11 | Upgrade
|
| Total Current Liabilities | 18.13 | 25.14 | 24.42 | 27.36 | 26.13 | Upgrade
|
| Long-Term Leases | 3.44 | 5.72 | 9.99 | 6.43 | 10.31 | Upgrade
|
| Other Long-Term Liabilities | 0.32 | 0.29 | 0.29 | 0.29 | 0.28 | Upgrade
|
| Total Liabilities | 21.88 | 31.16 | 34.7 | 34.08 | 36.72 | Upgrade
|
| Common Stock | 633.33 | 633.33 | 532.56 | 532.21 | 532.21 | Upgrade
|
| Additional Paid-In Capital | 142.17 | 141.52 | 8.02 | 95.74 | 94.92 | Upgrade
|
| Retained Earnings | -253.08 | -199.32 | -148.74 | -192.06 | -138.57 | Upgrade
|
| Comprehensive Income & Other | -0.99 | -6.88 | -11.25 | -11.32 | -5.59 | Upgrade
|
| Total Common Equity | 521.42 | 568.65 | 380.58 | 424.58 | 482.98 | Upgrade
|
| Minority Interest | 79.4 | 95.07 | 97.37 | 95.2 | 96.06 | Upgrade
|
| Shareholders' Equity | 600.82 | 663.72 | 477.95 | 519.78 | 579.03 | Upgrade
|
| Total Liabilities & Equity | 622.7 | 694.87 | 512.65 | 553.86 | 615.75 | Upgrade
|
| Total Debt | 4.75 | 10.87 | 14.39 | 10.31 | 14.73 | Upgrade
|
| Net Cash (Debt) | 366.47 | 354.84 | 272.88 | 320.53 | 356.32 | Upgrade
|
| Net Cash Growth | 3.28% | 30.03% | -14.87% | -10.04% | -8.84% | Upgrade
|
| Net Cash Per Share | 5.79 | 6.15 | 5.13 | 6.02 | 6.70 | Upgrade
|
| Filing Date Shares Outstanding | 63.27 | 63.33 | 53.26 | 53.22 | 53.22 | Upgrade
|
| Total Common Shares Outstanding | 63.27 | 63.33 | 53.26 | 53.22 | 53.22 | Upgrade
|
| Working Capital | 391.87 | 392.94 | 301.47 | 332.52 | 374.41 | Upgrade
|
| Book Value Per Share | 8.24 | 8.98 | 7.15 | 7.98 | 9.07 | Upgrade
|
| Tangible Book Value | 461.48 | 502.33 | 306.9 | 342.87 | 393.18 | Upgrade
|
| Tangible Book Value Per Share | 7.29 | 7.93 | 5.76 | 6.44 | 7.39 | Upgrade
|
| Land | - | 52.94 | 52.94 | 52.94 | 52.94 | Upgrade
|
| Buildings | - | 8.14 | 8.14 | 8.14 | 8.14 | Upgrade
|
| Machinery | - | 15.57 | 25.15 | 48.47 | 47.34 | Upgrade
|
| Leasehold Improvements | - | - | - | 0.82 | 0.82 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.